vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and NorthEast Community Bancorp, Inc. (NECB). Click either name above to swap in a different company.
NorthEast Community Bancorp, Inc. is the larger business by last-quarter revenue ($26.4M vs $13.8M, roughly 1.9× Gossamer Bio, Inc.). NorthEast Community Bancorp, Inc. runs the higher net margin — 40.9% vs -342.3%, a 383.2% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 3.9%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
NorthEast Community Bancorp, Inc. (MD) is a U.S.-based bank holding company operating primarily in the Mid-Atlantic region. It provides a comprehensive suite of consumer and commercial banking services, including deposit products, mortgage loans, small business financing, and wealth management solutions to individual and local enterprise clients.
GOSS vs NECB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $26.4M |
| Net Profit | $-47.2M | $10.8M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | 59.0% |
| Net Margin | -342.3% | 40.9% |
| Revenue YoY | 47.1% | 3.9% |
| Net Profit YoY | -43.0% | 5.8% |
| EPS (diluted) | $-0.21 | $0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $26.4M | ||
| Q3 25 | $13.3M | $27.0M | ||
| Q2 25 | — | $25.9M | ||
| Q1 25 | — | $25.5M | ||
| Q4 24 | — | $25.4M | ||
| Q3 24 | — | $27.6M | ||
| Q2 24 | $95.8M | $27.0M | ||
| Q1 24 | $0 | $25.5M |
| Q4 25 | $-47.2M | $10.8M | ||
| Q3 25 | $-48.2M | $11.9M | ||
| Q2 25 | — | $11.2M | ||
| Q1 25 | — | $10.6M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | — | $12.7M | ||
| Q2 24 | $49.2M | $12.8M | ||
| Q1 24 | $-41.9M | $11.4M |
| Q4 25 | -333.6% | 59.0% | ||
| Q3 25 | -369.4% | 61.6% | ||
| Q2 25 | — | 59.5% | ||
| Q1 25 | — | 57.4% | ||
| Q4 24 | — | 57.0% | ||
| Q3 24 | — | 63.6% | ||
| Q2 24 | 54.3% | 65.6% | ||
| Q1 24 | — | 62.7% |
| Q4 25 | -342.3% | 40.9% | ||
| Q3 25 | -362.7% | 44.0% | ||
| Q2 25 | — | 43.1% | ||
| Q1 25 | — | 41.4% | ||
| Q4 24 | — | 40.1% | ||
| Q3 24 | — | 45.9% | ||
| Q2 24 | 51.4% | 47.5% | ||
| Q1 24 | — | 44.5% |
| Q4 25 | $-0.21 | $0.78 | ||
| Q3 25 | $-0.21 | $0.87 | ||
| Q2 25 | — | $0.82 | ||
| Q1 25 | — | $0.78 | ||
| Q4 24 | — | $0.74 | ||
| Q3 24 | — | $0.95 | ||
| Q2 24 | $0.22 | $0.97 | ||
| Q1 24 | $-0.19 | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $81.2M |
| Total DebtLower is stronger | — | $70.0M |
| Stockholders' EquityBook value | $-122.8M | $351.7M |
| Total Assets | $172.2M | $2.1B |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $81.2M | ||
| Q3 25 | $180.2M | $64.3M | ||
| Q2 25 | — | $59.4M | ||
| Q1 25 | — | $89.5M | ||
| Q4 24 | — | $78.3M | ||
| Q3 24 | — | $97.8M | ||
| Q2 24 | $354.5M | $113.9M | ||
| Q1 24 | $244.4M | $107.4M |
| Q4 25 | — | $70.0M | ||
| Q3 25 | — | $170.0M | ||
| Q2 25 | — | $135.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $47.0M | ||
| Q1 24 | — | $47.0M |
| Q4 25 | $-122.8M | $351.7M | ||
| Q3 25 | $-82.3M | $344.0M | ||
| Q2 25 | — | $336.7M | ||
| Q1 25 | — | $327.2M | ||
| Q4 24 | — | $318.3M | ||
| Q3 24 | — | $309.6M | ||
| Q2 24 | $81.5M | $300.0M | ||
| Q1 24 | $26.7M | $288.9M |
| Q4 25 | $172.2M | $2.1B | ||
| Q3 25 | $208.8M | $2.1B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $373.4M | $1.9B | ||
| Q1 24 | $259.4M | $1.9B |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $52.6M |
| Free Cash FlowOCF − Capex | — | $50.8M |
| FCF MarginFCF / Revenue | — | 192.3% |
| Capex IntensityCapex / Revenue | 0.0% | 6.6% |
| Cash ConversionOCF / Net Profit | — | 4.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | $89.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $52.6M | ||
| Q3 25 | $-36.2M | $14.1M | ||
| Q2 25 | — | $15.6M | ||
| Q1 25 | — | $10.9M | ||
| Q4 24 | — | $48.7M | ||
| Q3 24 | — | $14.4M | ||
| Q2 24 | $116.3M | $11.1M | ||
| Q1 24 | $-52.3M | $12.9M |
| Q4 25 | — | $50.8M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $10.6M | ||
| Q4 24 | — | $48.2M | ||
| Q3 24 | — | $14.2M | ||
| Q2 24 | — | $11.0M | ||
| Q1 24 | — | $12.8M |
| Q4 25 | — | 192.3% | ||
| Q3 25 | — | 50.5% | ||
| Q2 25 | — | 57.3% | ||
| Q1 25 | — | 41.4% | ||
| Q4 24 | — | 189.3% | ||
| Q3 24 | — | 51.5% | ||
| Q2 24 | — | 40.8% | ||
| Q1 24 | — | 50.3% |
| Q4 25 | 0.0% | 6.6% | ||
| Q3 25 | 0.0% | 1.6% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | 0.0% | 0.5% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 4.86× | ||
| Q3 25 | — | 1.18× | ||
| Q2 25 | — | 1.40× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | — | 4.77× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | 2.36× | 0.87× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
